Cargando…
Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines
Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes Coronavirus Disease 2019 (COVID-19), which has reached pandemic proportions. A number of effective vaccines have been produced, including mRNA vaccines and viral vector vaccines, which are now being implemented on a l...
Autores principales: | Rijkers, Ger T., Weterings, Nynke, Obregon-Henao, Andres, Lepolder, Michaëla, Dutt, Taru S., van Overveld, Frans J., Henao-Tamayo, Marcela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402319/ https://www.ncbi.nlm.nih.gov/pubmed/34451973 http://dx.doi.org/10.3390/vaccines9080848 |
Ejemplares similares
-
The “original antigenic sin” and its relevance for SARS-CoV-2 (COVID-19) vaccination
por: Rijkers, Ger T., et al.
Publicado: (2021) -
Cyto-Feature Engineering: A Pipeline for Flow Cytometry Analysis to Uncover Immune Populations and Associations with Disease
por: Fox, Amy, et al.
Publicado: (2020) -
The Impact of SARS-CoV-2 Immune Status and Societal Restrictions in Controlling COVID-19 across the World
por: Stroo, Jasmijn, et al.
Publicado: (2023) -
Gr1(int)CD11b(+) Myeloid-Derived Suppressor Cells in Mycobacterium tuberculosis Infection
por: Obregón-Henao, Andrés, et al.
Publicado: (2013) -
Preservation of neutralizing antibody function in COVID‐19 convalescent plasma treated using a riboflavin and ultraviolet light‐based pathogen reduction technology
por: Yonemura, Susan, et al.
Publicado: (2021)